Chris Dow

700 total citations
13 papers, 558 citations indexed

About

Chris Dow is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Chris Dow has authored 13 papers receiving a total of 558 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 4 papers in Surgery and 4 papers in Molecular Biology. Recurrent topics in Chris Dow's work include Helicobacter pylori-related gastroenterology studies (3 papers), Drug Transport and Resistance Mechanisms (2 papers) and Cancer-related gene regulation (2 papers). Chris Dow is often cited by papers focused on Helicobacter pylori-related gastroenterology studies (3 papers), Drug Transport and Resistance Mechanisms (2 papers) and Cancer-related gene regulation (2 papers). Chris Dow collaborates with scholars based in Australia. Chris Dow's co-authors include Michael Michael, Kathryn Field, Louise M. Judd, Wayne A. Phillips, Robert J. S. Thomas, Steven Rockman, Neville D. Yeomans, Elizabeth Vincan, S. Currie and Arthur Shulkes and has published in prestigious journals such as Journal of Biological Chemistry, Gastroenterology and The Lancet Oncology.

In The Last Decade

Chris Dow

10 papers receiving 549 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chris Dow Australia 8 216 212 177 120 80 13 558
Shusaku Ohira Japan 12 389 1.8× 147 0.7× 223 1.3× 73 0.6× 80 1.0× 41 613
Alexandre Dos Santos France 11 234 1.1× 235 1.1× 173 1.0× 56 0.5× 125 1.6× 20 617
J. Mann United Kingdom 7 103 0.5× 213 1.0× 100 0.6× 107 0.9× 106 1.3× 10 571
Kenichi Taguchi Japan 16 211 1.0× 235 1.1× 214 1.2× 74 0.6× 91 1.1× 19 688
Mihaela Ignat France 12 200 0.9× 260 1.2× 99 0.6× 146 1.2× 96 1.2× 22 621
Yoshito Ikematsu Japan 14 291 1.3× 302 1.4× 253 1.4× 164 1.4× 129 1.6× 55 737
Hisatsugu Mouri Japan 13 176 0.8× 201 0.9× 318 1.8× 59 0.5× 93 1.2× 34 550
Yufu Ye China 12 155 0.7× 122 0.6× 155 0.9× 151 1.3× 33 0.4× 26 516
Bertil Lindmark Sweden 14 85 0.4× 153 0.7× 117 0.7× 64 0.5× 167 2.1× 50 609
Atsuro Sugita Japan 12 72 0.3× 173 0.8× 178 1.0× 76 0.6× 53 0.7× 27 456

Countries citing papers authored by Chris Dow

Since Specialization
Citations

This map shows the geographic impact of Chris Dow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chris Dow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chris Dow more than expected).

Fields of papers citing papers by Chris Dow

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chris Dow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chris Dow. The network helps show where Chris Dow may publish in the future.

Co-authorship network of co-authors of Chris Dow

This figure shows the co-authorship network connecting the top 25 collaborators of Chris Dow. A scholar is included among the top collaborators of Chris Dow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chris Dow. Chris Dow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Dow, Chris, et al.. (2021). Amyloidosis of the distal ileum: A stricturing lesion is not always Crohn's disease. ANZ Journal of Surgery. 92(3). 576–578.
2.
Moghimi, Ali, et al.. (2014). The effect of immersion formaldehyde fixation on placental weight. Pathology. 46. S75–S75.
3.
Boussioutas, Alex, et al.. (2011). Gastrointestinal: Tuberculosis of the sigmoid colon—a cautionary tale. Journal of Gastroenterology and Hepatology. 26(11). 1692–1692.
4.
Dow, Chris, et al.. (2008). CONGENITAL PORTOCAVAL SHUNT‐ASSOCIATED LIVER LESIONS IN A PATIENT WITH CANCER. ANZ Journal of Surgery. 78(7). 613–614. 4 indexed citations
5.
Field, Kathryn, Chris Dow, & Michael Michael. (2008). Part I: Liver function in oncology: biochemistry and beyond. The Lancet Oncology. 9(11). 1092–1101. 102 indexed citations
6.
Judd, Louise M., Trevelyan R. Menheniott, Ian Kronborg, et al.. (2007). Augmented gp130‐mediated cytokine signalling accompanies human gastric cancer progression. The Journal of Pathology. 213(2). 140–151. 91 indexed citations
7.
Judd, Louise M., Barbara M. Alderman, Meegan Howlett, et al.. (2003). Gastric cancer development in mice lacking the SHP2 binding site on the IL-6 family co-receptor gp130. Gastroenterology. 126(1). 196–207. 144 indexed citations
8.
Laurie, R., Michael Chao, & Chris Dow. (2003). Radiation induced liver disease: is hereditary haemochromatosis a risk factor?. Journal of Radiotherapy in Practice. 3(2). 101–104. 1 indexed citations
9.
Giraud, A, et al.. (2002). Biliary epithelial trefoil peptide expression is increased in biliary diseases. Histopathology. 40(3). 261–268. 44 indexed citations
10.
Rockman, Steven, S. Currie, Elizabeth Vincan, et al.. (2001). Id2 Is a Target of the β-Catenin/T Cell Factor Pathway in Colon Carcinoma. Journal of Biological Chemistry. 276(48). 45113–45119. 122 indexed citations
11.
Cunnington, David, et al.. (2000). Necrotizing Pulmonary Granulomata in a Marijuana Smoker. CHEST Journal. 117(5). 1511–1514. 15 indexed citations
12.
Phillips, Wayne A., et al.. (2000). Methylation of exon 2 of p16 is associated with late stage oesophageal cancer. Cancer Letters. 150(1). 57–62. 15 indexed citations
13.
Burns, Wendy C., et al.. (1997). Direct PCR from Paraffin-Embedded Tissue. BioTechniques. 22(4). 638–640. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026